RxSight, Inc.
RxSight, Inc. (RXST) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · RXST · as of Sep 30, 2025
Ownership Breakdown
163
Institutional Holders
▼ 16 vs Q2
$299.08M
Total Inst. Value
▼ $182.43M vs Q2
41.40M
Shares Outstanding
freeFloat 94.64%
33.27M
13F Shares Held
▼ 3.77M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
RXST largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. ophthalmic goods | 2.70M | 6.63% | 6.63% | $24.30B | Nov 12, 2025 | ▼ 304.4K |
MILLENNIUM MANAGEMENT LLC ophthalmic goods | 2.19M | 5.38% | 5.38% | $19.72B | Nov 14, 2025 | ▲ 1.24M |
VANGUARD GROUP INC ophthalmic goods | 2.15M | 5.27% | 5.27% | $19.30B | Nov 7, 2025 | ▼ 131.4K |
D. E. SHAW & CO., INC. ophthalmic goods | 1.83M | 4.50% | 4.50% | $16.49B | Nov 14, 2025 | ▲ 512.6K |
ARTISAN PARTNERS LIMITED PARTNERSHIP ophthalmic goods | 1.75M | 4.30% | 4.30% | $15.77B | Nov 12, 2025 | ▼ 498.9K |
NO STREET GP LP ophthalmic goods | 1.63M | 3.99% | 3.99% | $14.61B | Nov 14, 2025 | ▲ 425.0K |
CITADEL ADVISORS LLC ophthalmic goods | 1.29M | 3.17% | 3.17% | $11.60B | Nov 14, 2025 | ▲ 262.3K |
DEUTSCHE BANK AG\ ophthalmic goods | 967.6K | 2.37% | 2.37% | $8.70B | Nov 13, 2025 | ▼ 261.6K |
BNP PARIBAS ARBITRAGE, SNC ophthalmic goods | 903.8K | 2.22% | 2.22% | $8.13B | Nov 13, 2025 | ▲ 422.8K |
MORGAN STANLEY ophthalmic goods | 844.7K | 2.07% | 2.07% | $7.59B | May 27, 2026 | ▼ 157.1K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
25
Increased
+7.47M shares3
New Positions
first time holders19
Decreased
−3.22M shares0
Sold Out
fully exitedNet shares change (top 50)
+4.26M
+7.47M / −3.22M
Net new holders
+9
3 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
RXST insider trading · insider activity
Source: SEC Form 4
3
Buy transactions
2
Sell transactions
1.50
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Wilterding Mark Chief Financial Officer | Feb 28, 2026 | Tax Withhold | 8,068 | $7.61 | $61.4K | 12.4K | Form 4 ↗ |
Gaines Scott Chief Customer Officer | Feb 28, 2026 | Tax Withhold | 2,580 | $7.61 | $19.6K | 14.8K | Form 4 ↗ |
Wilterding Mark Chief Financial Officer | Jan 12, 2026 | Award | 258,770 | $10.09 | $2.61M | 258.8K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
RxSight, Inc. (RXST) is primarily owned by institutional investors, who hold approximately 80.4% of total shares outstanding. Company insiders own approximately 5.36%, while retail and public investors account for the remaining 14.27%.
The largest institutional shareholder of RxSight, Inc. is BLACKROCK, INC., holding approximately 2.70 million shares — equal to 6.63% of outstanding shares — as of September 30, 2025.
A total of 163 institutional investors currently hold RXST stock, with a combined institutional value of approximately $299,075,211 as of the most recent 13F filing period.
Frequently asked questions
RXST ownershipRxSight, Inc. (RXST) is primarily owned by institutional investors, who hold approximately 80.4% of shares. The largest shareholder is BLACKROCK, INC. with a 6.63% stake. Company insiders hold 5.36%. Data sourced from SEC Form 13F as of September 30, 2025.